TVTX – travere therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Travere Therapeutics (NASDAQ:TVTX) had its "neutral" rating reaffirmed by analysts at Piper Sandler.
Travere Therapeutics to Present at the Guggenheim Emerging Outlook Biotech Summit [Yahoo! Finance]
Travere Therapeutics to Present at the Guggenheim Emerging Outlook Biotech Summit
Is Travere Therapeutics (TVTX) Facing a Credibility Test in Its Disclosure and Risk Narrative? [Yahoo! Finance]
TVTX ALERT: Investigation Launched into Travere Therapeutics, Inc., Robbins Geller Rudman & Dowd LLP Encourages Investors and Potential Witnesses to Contact Law Firm
Form SCHEDULE 13G Travere Therapeutics, Filed by: STATE STREET CORP
Form 4 Travere Therapeutics, For: Feb 04 Filed by: Cline Christopher R.
Form 4 Travere Therapeutics, For: Feb 04 Filed by: Inrig Jula
Form 4 Travere Therapeutics, For: Feb 04 Filed by: REED ELIZABETH E
Form 144 Travere Therapeutics, Filed by: Inrig Jula
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.